10.700
+7,00%
2026-10-16
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -26.8% | +714.7% | 2 / 3 | -10.9% | +0.89 pp | -0.64 pp | +6.8% | 0.08 | 7.77 | 247 | −10,9% | 7,3 | −26,8% | 7.77 | 9.27 | −16,1% |
| Pts | 0 | 12 | 8 | 0 | 8 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 10.700 (close price on 2026-10-16)EPS (TTM): 1.377
Financial charts
1.Revenue & growth
VND bn247Q3/26
1.Revenue & growth
VND bn247Q3/26
2.Profit & growth
VND bn7,29Q3/26
3.Profit mix (Penman)
VND bn39,3Q3/26
4.Margins & cost structure
%17.6%Q3/26
5.Returns & cash cycle
% · days8.9%Q3/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn789Q3/26
8.Funding & debt health
VND bn · times789Q3/26
9.Revenue backlog
VND bn15,6Q3/26
10.Valuation
times · %7,8×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %292Q3/26
Adjusted EPS growth, latest quarter
-26.8%
Average adjusted EPS growth, 3 quarters
715%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26